The NICU Antibiotics and Outcomes (NANO) trial: a randomized multicenter clinical trial assessing empiric antibiotics and clinical outcomes in newborn preterm infants

Overview of attention for article published in Trials, May 2022

Altmetric Badge

Mentioned by

twitter: 20 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 73 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 28 X posts from 20 X users, with an upper bound of 58,019 followers.

RT @EBNEO: #HotTopicsNeo2023 "The Double-Edged Sword of Antibiotics for Early-Onset Sepsis" 🦠🧫 The 1st speaker is @morowitzmj "The NICU An…

12 Dec 2023

Reply Repost Favourite

RT @EBNEO: #HotTopicsNeo2023 "The Double-Edged Sword of Antibiotics for Early-Onset Sepsis" 🦠🧫 The 1st speaker is @morowitzmj "The NICU An…

11 Dec 2023

Reply Repost Favourite

RT @EBNEO: #HotTopicsNeo2023 "The Double-Edged Sword of Antibiotics for Early-Onset Sepsis" 🦠🧫 The 1st speaker is @morowitzmj "The NICU An…

11 Dec 2023

Reply Repost Favourite

#HotTopicsNeo2023 "The Double-Edged Sword of Antibiotics for Early-Onset Sepsis" 🦠🧫 The 1st speaker is @morowitzmj "The NICU Antibiotics and Outcomes (NANO) Trial of Risks and Benefits of Perinatal Antibiotics in VLBW Infants", study here https://t.co/20c

11 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 24 additional X posts.